Ministry of Health, Labour and Welfare (MHLW), with the Pharmaceuticals and Medical Devices Agency (PMDA) doing the scientific review and safety monitoring

Is DSIP (delta sleep-inducing peptide) legal in Japan?

Not approvedNot an approved medicine in Japan; DSIP (delta sleep-inducing peptide) is absent from PMDA's approved-drug lists and package-insert database

Not approved as a medicine here.

DSIP (delta sleep-inducing peptide) has no approval in PMDA's approved-drug lists (April 2004 to September 2026), and PMDA's package-insert database has no matching product. Under the PMD Act a drug needs MHLW approval (Art. 14) before it is marketed, selling one marketed without approval is prohibited (Art. 55(2)) and advertising it is banned (Art. 68). No MHLW or PMDA notice naming it was found, so we do not classify it as specifically banned. Individuals may import a prescription drug for their own use up to one month's supply and may not pass it on, and physicians may import an unapproved drug for a patient under their own responsibility.

Last verified 2026-09-29 · how we verify

DSIP (delta sleep-inducing peptide) elsewhere

Sources (5)

  1. 01Approved new drugs list (Japanese), fiscal 2026 to date, covering approvals from May to September 2026 (承認品目一覧(新医薬品))Pharmaceuticals and Medical Devices Agency (PMDA) · 2026-09 · accessed 2026-09-29
  2. 02List of Approved Drugs, April 2004 to February 2026 (new drugs)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026 · accessed 2026-09-29
  3. 03Prescription drug package insert and review report search (医療用医薬品 添付文書等情報検索)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026-09-29 · accessed 2026-09-29
  4. 04Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (PMD Act), consolidated textDigital Agency (e-Gov Law Search) · 2026-05-21 · accessed 2026-09-29
  5. 05Personal import of pharmaceuticals and related products (医薬品等の個人輸入について)Ministry of Health, Labour and Welfare (MHLW) · 2025 · accessed 2026-09-29